Literature DB >> 4591149

Treatment of hypertension with a new beta-blocking agent, pindolol (Visken).

I Persson, J Ulrich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4591149     DOI： 10.1007/bf00644734

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN： 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  8 in total

1.  Effect of propranolol on elevated arterial blood pressure.

Authors:  D W Richardson; J Freund; A S Gear; H P Mauck; L W Preston
Journal:  Circulation       Date:  1968-04       Impact factor: 29.690

2.  The paradox of beta-adrenergic blockade in hypertension.

Authors:  E D Frohlich; R C Tarazi; H P Dustan; I H Page
Journal:  Circulation       Date:  1968-03       Impact factor: 29.690

3.  Plasma propranolol levels in adults with observations in four children.

Authors:  D G Shand; E M Nuckolls; J A Oates
Journal:  Clin Pharmacol Ther       Date:  1970 Jan-Feb       Impact factor: 6.875

4.  [Comparative studies with beta-receptor blocking agents and quinidine].

Authors:  K Saameli
Journal:  Helv Physiol Pharmacol Acta       Date:  1967

5.  Propranolol in hypertension.

Authors:  B N Prichard; P M Gillam
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

6.  USE OF PROPRANOLOL (INDERAL) IN TREATMENT OF HYPERTENSION.

Authors:  B N PRICHARD; P M GILLAM
Journal:  Br Med J       Date:  1964-09-19

7.  Treatment of hypertension with propranolol.

Authors:  B N Prichard; P M Gillam
Journal:  Br Med J       Date:  1969-01-04

8.  A comparison of some cardiovascular properties of propranolol, MJ 1999 and quinidine in relation to their effects in hypertensive animals.

Authors:  J B Farmer; G P Levy
Journal:  Br J Pharmacol       Date:  1968-09       Impact factor: 8.739
  8 in total
  7 in total

1.  Decrease in plasma noradrenaline levels following long-term treatment with prindolol in patients with essential hypertension.

Authors:  H M Brecht; F Banthien; W Schoeppe
Journal:  Klin Wochenschr       Date:  1976-11-15

2.  Some clinical pharmacological studies with indoramin, with observations on its therapeutic usefulness.

Authors:  C de White; R B Royds; P Turner
Journal:  Postgrad Med J       Date:  1974-12       Impact factor: 2.401

3.  Prolonged effect of antihypertensive agents.

Authors:  C de B White; R B Royds; P Turner
Journal:  Br Med J       Date:  1974-07-06

4.  [Effect of the beta-receptor-blocker prindolol on renal hypertension (author's transl)].

Authors:  K Undeutsch; H G Sieberth; K A Meurer
Journal:  Klin Wochenschr       Date:  1976-11-15

5.  Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. II. Relationship to its effect on blood pressure and plasma renin activity.

Authors:  P Collste; K Haglund; M Frisk-Holmberg; M L Orme; M D Rawlins; J Ostman
Journal:  Eur J Clin Pharmacol       Date:  1976-06-15       Impact factor: 2.953

6.  Combination therapy of essential hypertension with pindolol (Visken) and hydralazine.

Authors:  I Persson
Journal:  Eur J Clin Pharmacol       Date:  1975-12-19       Impact factor: 2.953

7.  The antihypertensive effect of pindolol (Visken) alone and combined with clopamide (Brinaldix).

Authors:  I Persson
Journal:  Eur J Clin Pharmacol       Date:  1977-07-19       Impact factor: 2.953
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.